Company Overview

Update
Founded:
2010
Founders:
Adam Fleisher, PJ Anand
Headquarters:
Ayer, MA
Funding:
$6.80M
Categories:
Biotechnology

Alcyone Lifesciences develops a platform of technology that optimizes molecular therapy for the brain.

Description

Update

Alcyone Lifesciences was founded in 2010 to address the unmet needs in treatment of chronic neuropathological conditions. For many neurologic conditions there are identified molecular targets, but the blood brain barrier prevents drugs addressing those targets from reaching diseased brain regions in a controlled and targeted manner. In addition, there is a fundamental need for control and precision in molecular therapy to the CNS. Alcyone Lifesciences has created a best-in-class platform technology which can optimize molecular therapy to the brain

Current Team (4)

Update
  • 7f63db4fcbf2c94efef752f70998925e

    Deep Singh

    Director of Product Development and Program Manager
  • 69af121e8ca59cb060a2f029db4123cb

    Elsa Abruzzo

    Vice President of Regulatory, Quality and Clinical Affairs
  • 0a7ed79cb93801cca9c9b428c89ee7e8

    Todd Tomba

    Vice President of Product Development
  • 632ab2caf40c10da33f4630f6bc7e3e1

    PJ Anand

    Chief Executive Officer and Founder & Board of Directors

Board Members and Advisors (4)

Update

Funding Rounds (3) - $6.80M

Update

Investors (2)

Update

Offices/Locations (1)

Update
  • Headquarters

    75 Sandy Point Road

    Unite 21

    Ayer, MA 01432

    USA